JCM
GILD icon

Jacobsen Capital Management’s Gilead Sciences GILD Stock Holding History

Jacobsen Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Hold
1,994
– – 0.09% 87
2025
Q4 		$245K Sell
1,994
-22
-1% -$2.67K 0.08% 100
2025
Q3 		$224K Sell
2,016
-2
-0.1% -$227 0.08% 112
2025
Q2 		$224K Buy
+2,018
New +$215K 0.08% 102

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jacobsen Capital Management's GILD Position: Q1 2026 in Review

Jacobsen Capital Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,994 shares worth $278K. The position accounts for 0.09% of the portfolio, ranked #87.

Jacobsen Capital Management first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jacobsen Capital Management held 1,994 shares of Gilead Sciences worth $278K as of Q1 2026.
  • Jacobsen Capital Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.09% of Jacobsen Capital Management's portfolio in Q1 2026, its #87 holding.
  • Jacobsen Capital Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jacobsen Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.